CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 40 filers reported holding CHEMBIO DIAGNOSTICS INC in Q4 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $690,482 | +101.3% | 1,561,470 | 0.0% | 0.00% | – |
| Q4 2022 | $343,055 | -39.2% | 1,561,470 | -0.0% | 0.00% | – |
| Q3 2022 | $564,000 | -21.4% | 1,562,014 | +41.4% | 0.00% | – |
| Q2 2022 | $718,000 | -20.8% | 1,104,564 | 0.0% | 0.00% | – |
| Q1 2022 | $906,000 | -43.5% | 1,104,564 | -21.4% | 0.00% | – |
| Q4 2021 | $1,603,000 | -28.6% | 1,405,785 | +56.6% | 0.00% | – |
| Q3 2021 | $2,245,000 | -11.6% | 897,694 | +5.0% | 0.00% | – |
| Q2 2021 | $2,540,000 | -21.3% | 855,245 | -7.0% | 0.00% | – |
| Q1 2021 | $3,227,000 | -34.6% | 919,308 | -11.5% | 0.00% | – |
| Q4 2020 | $4,932,000 | -22.3% | 1,038,283 | -20.5% | 0.00% | – |
| Q3 2020 | $6,344,000 | +77.9% | 1,305,568 | +19.0% | 0.00% | – |
| Q2 2020 | $3,567,000 | +2.0% | 1,097,208 | +60.6% | 0.00% | – |
| Q1 2020 | $3,497,000 | +13.1% | 683,056 | +0.7% | 0.00% | – |
| Q4 2019 | $3,092,000 | -25.5% | 678,061 | 0.0% | 0.00% | – |
| Q3 2019 | $4,150,000 | +1.7% | 678,061 | +1.2% | 0.00% | – |
| Q2 2019 | $4,079,000 | +9.7% | 669,832 | 0.0% | 0.00% | – |
| Q1 2019 | $3,717,000 | -0.5% | 669,832 | +1.5% | 0.00% | – |
| Q4 2018 | $3,734,000 | -32.9% | 659,809 | +24.6% | 0.00% | – |
| Q3 2018 | $5,561,000 | -3.9% | 529,604 | +1.6% | 0.00% | – |
| Q2 2018 | $5,785,000 | +38.4% | 521,154 | -0.3% | 0.00% | – |
| Q1 2018 | $4,181,000 | +40.2% | 522,625 | +43.7% | 0.00% | – |
| Q4 2017 | $2,982,000 | +31.5% | 363,654 | -0.6% | 0.00% | – |
| Q3 2017 | $2,267,000 | +5.6% | 365,754 | +3.1% | 0.00% | – |
| Q2 2017 | $2,147,000 | +14.2% | 354,797 | 0.0% | 0.00% | – |
| Q1 2017 | $1,880,000 | -22.0% | 354,797 | +0.0% | 0.00% | – |
| Q4 2016 | $2,411,000 | -6.8% | 354,697 | +1.1% | 0.00% | – |
| Q3 2016 | $2,587,000 | +104.7% | 350,938 | +127.3% | 0.00% | – |
| Q2 2016 | $1,264,000 | +41.9% | 154,390 | +3.9% | 0.00% | – |
| Q1 2016 | $891,000 | +14.4% | 148,641 | +1.6% | 0.00% | – |
| Q4 2015 | $779,000 | -99.5% | 146,241 | -96.9% | 0.00% | -100.0% |
| Q3 2015 | $165,809,000 | +23485.9% | 4,777,855 | +3235.5% | 0.01% | – |
| Q2 2015 | $703,000 | +24.0% | 143,244 | 0.0% | 0.00% | – |
| Q1 2015 | $567,000 | +1.8% | 143,244 | +1.2% | 0.00% | – |
| Q4 2014 | $557,000 | +6.9% | 141,544 | +1.1% | 0.00% | – |
| Q3 2014 | $521,000 | +8.5% | 140,044 | 0.0% | 0.00% | – |
| Q2 2014 | $480,000 | 0.0% | 140,044 | 0.0% | 0.00% | – |
| Q1 2014 | $480,000 | +3.0% | 140,044 | +1.4% | 0.00% | – |
| Q4 2013 | $466,000 | -7.4% | 138,144 | 0.0% | 0.00% | – |
| Q3 2013 | $503,000 | +308.9% | 138,144 | +461.9% | 0.00% | – |
| Q2 2013 | $123,000 | – | 24,586 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Penbrook Management LLC | 344,060 | $1,634,000 | 1.26% |
| Union Square Park Capital Management, LLC | 400,000 | $1,900,000 | 0.76% |
| P.A.W. CAPITAL CORP | 100,000 | $475,000 | 0.42% |
| PRECEPT MANAGEMENT LLC | 150,000 | $713,000 | 0.29% |
| Newbridge Financial Services Group, Inc. | 73,500 | $349,000 | 0.29% |
| SANDERS MORRIS HARRIS LLC | 183,584 | $990,000 | 0.22% |
| FRIESS ASSOCIATES LLC | 555,000 | $2,636,000 | 0.19% |
| PERRITT CAPITAL MANAGEMENT INC | 30,651 | $146,000 | 0.09% |
| Ikarian Capital, LLC | 219,109 | $1,041,000 | 0.05% |
| SEGALL BRYANT & HAMILL, LLC | 705,823 | $3,352,000 | 0.04% |